June 7, 2013
Peabody, Mass. -- JEOL USA, Inc. (Peabody, MA) has concluded an OEM agreement with Zoex Corporation (Houston, TX) to offer the Zoex comprehensive two-dimensional gas chromatography (GC x GC) technology with the new JEOL AccuTOF GCV 4G high-resolution time-of-flight mass spectrometer system. “We are very excited about the partnership with Zoex. The combination of comprehensive [...]
Sartorius Stedim Biotech to be included in the SBF 120 index
June 7, 2013
Aubagne | Goettingen, – Sartorius Stedim Biotech (SSB), a leading international supplier for the pharmaceutical and biotech industries, is to be included in the SBF 120 index of Euronext Paris, the French stock exchange. Following yesterday’s quarterly review of the Euronext Paris indices, the meeting of the Scientific NYSE Euronext Committee for Indices decided to [...]
June 7, 2013
Denver, Colo. - Hach Company (www.hach.com) will be exhibiting at American Water Works’ (AWWA) Annual Conference and Exhibition ACE13. The focus of their program is to help water professionals optimize their process to save them time and money as well as feature a lineup of new and innovative products. Featured Hach products at ACE13 will [...]
June 7, 2013
BILLERICA, Mass.-- EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, was named a finalist in the New Product of the Year category of the 2013 American Business Awards for two products introduced this past year: the Muse™ Cell Analyzer and the Direct Detect® Protein Quantitation System. The awards are given as [...]
June 7, 2013
Tokyo, - NEC Corporation (NEC; TSE: 6701) and NEC New Zealand carried out a field trial with the Institute of Environmental Science & Research Limited (ESR) to evaluate NEC's Portable DNA Analyzer that is currently under development. This Analyzer extracts and analyzes human DNA for personal identification purposes. This evaluation of the Portable DNA Analyzer, [...]
Tecan successfully completes OEM development of Dako Omnis
June 7, 2013
Männedorf, Switzerland, - The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the OEM development of the Dako Omnis. In May 2011, Tecan signed a major OEM agreement with Dako, an Agilent Technologies Company (NYSE: A) and worldwide provider of cancer diagnostics, for the development and supply of an advanced [...]
Fluxion Delivers First Commercial Shipments of IsoFlux™ System for Circulating Tumor Cell Analysis
June 6, 2013
SOUTH SAN FRANCISCO, Calif.-- Fluxion Biosciences, Inc. announced today that the first round of IsoFlux instruments has been delivered to customers around the world. Initially announced in November, the IsoFlux System is an automated instrument and microfluidic cartridge for high sensitivity enrichment of rare cells such as circulating tumor cells (CTCs), stem cells, and immune [...]
New centre will decipher roles of nature and nurture in human health
June 6, 2013
The MRC-NIHR Phenome Centre will examine around one hundred thousand blood and urine samples every year. It will analyse phenomes - the biological results of people's genes and environment - to help determine the causes of disease and indicate how treatments can be tailored for individual patients. The centre will enable scientists to better understand [...]
T2 Biosystems Appoints Marc Jones and Frédéric Sweeney, Ph.D., to Senior Management Team
June 6, 2013
Lexington, MA, – T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the appointments of Marc Jones as Chief Financial Officer and Frédéric Sweeney, Ph.D., as Senior Director, Business Development. “Marc’s and Fred’s combined financial and business development expertise are ideal additions to the T2 Biosystems leadership team as we prepare [...]
BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits
June 6, 2013
Madison, WI - Methyltransferases are key players in epigenetic control of gene expression and have become the targets of intensive public and private drug discovery efforts. Unfortunately, the first step in developing epigenetic drugs – identification of specific inhibitors for target enzymes – has been plagued by problems in getting methyltransferase enzymes to function correctly [...]
